# A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's

> **NCT00331149** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 343 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Ropinirole prolonged release
- **DRUG:** ropinirole immediate release

## Key facts

- **NCT ID:** NCT00331149
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06-20
- **Primary completion:** 2007-08-29
- **Final completion:** 2007-08-29
- **Target enrollment:** 343 (ACTUAL)
- **Last updated:** 2017-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00331149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00331149, "A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00331149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*